Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesca.fazio@uniroma1.it
Francesca Fazio
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
francesca.fazio@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity
CANCERS
2023
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
CELL DEATH & DISEASE
2023
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2023
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
LEUKEMIA RESEARCH REPORTS
2023
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance
JOURNAL OF EXTRACELLULAR VESICLES
2022
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia
LEUKEMIA & LYMPHOMA
2022
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: report from the Multiple Myeloma Gimema Lazio Group
EUROPEAN JOURNAL OF HAEMATOLOGY
2022
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
FRONTIERS IN IMMUNOLOGY
2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
FRONTIERS IN ONCOLOGY
2022
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study
EUROPEAN JOURNAL OF HAEMATOLOGY
2022
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
Monoclonal antibodies in multiple myeloma.
PANMINERVA MEDICA
2021
The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab
IntechOpen
2021
Relapsed/Refractory Multiple Myeloma Patients. A Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy
BLOOD
2021
Single Molecule Real-Time Sequencing of the M Protein (SMaRT M-Seq): Toward Personalized Medicine Approaches in Monoclonal Gammopathies
BLOOD
2021
Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic malignancies in real-world practice.
BLOOD
2021
Real-World Patterns of Utilization and Outcome of Market Approved Lenalidomide-Based Triplet Combinations in First Relapsed Multiple Myeloma Patients: Evidence from a Propensity Score Matched Analysis
BLOOD
2021
New dead/H-Box helicase gene (Ddx41) mutation in an italian family with recurrent leukemia.
LEUKEMIA & LYMPHOMA
2021
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma